These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 25220617)

  • 1. Protective role of olesoxime against wild-type α-synuclein-induced toxicity in human neuronally differentiated SHSY-5Y cells.
    Gouarné C; Tracz J; Paoli MG; Deluca V; Seimandi M; Tardif G; Xilouri M; Stefanis L; Bordet T; Pruss RM
    Br J Pharmacol; 2015 Jan; 172(1):235-45. PubMed ID: 25220617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inducible over-expression of wild type alpha-synuclein in human neuronal cells leads to caspase-dependent non-apoptotic death.
    Vekrellis K; Xilouri M; Emmanouilidou E; Stefanis L
    J Neurochem; 2009 Jun; 109(5):1348-62. PubMed ID: 19476547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endosulfine-alpha inhibits membrane-induced α-synuclein aggregation and protects against α-synuclein neurotoxicity.
    Ysselstein D; Dehay B; Costantino IM; McCabe GP; Frosch MP; George JM; Bezard E; Rochet JC
    Acta Neuropathol Commun; 2017 Jan; 5(1):3. PubMed ID: 28069058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Olesoxime prevents microtubule-targeting drug neurotoxicity: selective preservation of EB comets in differentiated neuronal cells.
    Rovini A; Carré M; Bordet T; Pruss RM; Braguer D
    Biochem Pharmacol; 2010 Sep; 80(6):884-94. PubMed ID: 20417191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Olesoxime protects embryonic cortical neurons from camptothecin intoxication by a mechanism distinct from BDNF.
    Gouarné C; Giraudon-Paoli M; Seimandi M; Biscarrat C; Tardif G; Pruss RM; Bordet T
    Br J Pharmacol; 2013 Apr; 168(8):1975-88. PubMed ID: 23278424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The protective role of AMP-activated protein kinase in alpha-synuclein neurotoxicity in vitro.
    Dulovic M; Jovanovic M; Xilouri M; Stefanis L; Harhaji-Trajkovic L; Kravic-Stevovic T; Paunovic V; Ardah MT; El-Agnaf OM; Kostic V; Markovic I; Trajkovic V
    Neurobiol Dis; 2014 Mar; 63():1-11. PubMed ID: 24269733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caspase-1 causes truncation and aggregation of the Parkinson's disease-associated protein α-synuclein.
    Wang W; Nguyen LT; Burlak C; Chegini F; Guo F; Chataway T; Ju S; Fisher OS; Miller DW; Datta D; Wu F; Wu CX; Landeru A; Wells JA; Cookson MR; Boxer MB; Thomas CJ; Gai WP; Ringe D; Petsko GA; Hoang QQ
    Proc Natl Acad Sci U S A; 2016 Aug; 113(34):9587-92. PubMed ID: 27482083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanism of olesoxime-mediated neuroprotection through targeting α-synuclein interaction with mitochondrial VDAC.
    Rovini A; Gurnev PA; Beilina A; Queralt-Martín M; Rosencrans W; Cookson MR; Bezrukov SM; Rostovtseva TK
    Cell Mol Life Sci; 2020 Sep; 77(18):3611-3626. PubMed ID: 31760463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic administration of cholesterol oximes in mice increases transcription of cytoprotective genes and improves transcriptome alterations induced by alpha-synuclein overexpression in nigrostriatal dopaminergic neurons.
    Richter F; Gao F; Medvedeva V; Lee P; Bove N; Fleming SM; Michaud M; Lemesre V; Patassini S; De La Rosa K; Mulligan CK; Sioshansi PC; Zhu C; Coppola G; Bordet T; Pruss RM; Chesselet MF
    Neurobiol Dis; 2014 Sep; 69():263-75. PubMed ID: 24844147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abberant alpha-synuclein confers toxicity to neurons in part through inhibition of chaperone-mediated autophagy.
    Xilouri M; Vogiatzi T; Vekrellis K; Park D; Stefanis L
    PLoS One; 2009; 4(5):e5515. PubMed ID: 19436756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of impaired membrane interactions on α-synuclein aggregation and neurotoxicity.
    Ysselstein D; Joshi M; Mishra V; Griggs AM; Asiago JM; McCabe GP; Stanciu LA; Post CB; Rochet JC
    Neurobiol Dis; 2015 Jul; 79():150-63. PubMed ID: 25931201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Axon degeneration and PGC-1α-mediated protection in a zebrafish model of α-synuclein toxicity.
    O'Donnell KC; Lulla A; Stahl MC; Wheat ND; Bronstein JM; Sagasti A
    Dis Model Mech; 2014 May; 7(5):571-82. PubMed ID: 24626988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inducible Alpha-Synuclein Expression Affects Human Neural Stem Cells' Behavior.
    Zasso J; Ahmed M; Cutarelli A; Conti L
    Stem Cells Dev; 2018 Jul; 27(14):985-994. PubMed ID: 29669468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Posttranslational modification and mutation of histidine 50 trigger alpha synuclein aggregation and toxicity.
    Xiang W; Menges S; Schlachetzki JC; Meixner H; Hoffmann AC; Schlötzer-Schrehardt U; Becker CM; Winkler J; Klucken J
    Mol Neurodegener; 2015 Mar; 10():8. PubMed ID: 25886189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endoplasmic reticulum stress and mitochondrial cell death pathways mediate A53T mutant alpha-synuclein-induced toxicity.
    Smith WW; Jiang H; Pei Z; Tanaka Y; Morita H; Sawa A; Dawson VL; Dawson TM; Ross CA
    Hum Mol Genet; 2005 Dec; 14(24):3801-11. PubMed ID: 16239241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha synuclein dimers and oligomers are increased in overexpressing conditions in vitro and in vivo.
    Marmolino D; Foerch P; Atienzar FA; Staelens L; Michel A; Scheller D
    Mol Cell Neurosci; 2016 Mar; 71():92-101. PubMed ID: 26711807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of the novel A53E alpha-synuclein mutation on its oligomerization and aggregation.
    Lázaro DF; Dias MC; Carija A; Navarro S; Madaleno CS; Tenreiro S; Ventura S; Outeiro TF
    Acta Neuropathol Commun; 2016 Dec; 4(1):128. PubMed ID: 27938414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumin protects against A53T alpha-synuclein-induced toxicity in a PC12 inducible cell model for Parkinsonism.
    Liu Z; Yu Y; Li X; Ross CA; Smith WW
    Pharmacol Res; 2011 May; 63(5):439-44. PubMed ID: 21237271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial damage by α-synuclein causes cell death in human dopaminergic neurons.
    Ganjam GK; Bolte K; Matschke LA; Neitemeier S; Dolga AM; Höllerhage M; Höglinger GU; Adamczyk A; Decher N; Oertel WH; Culmsee C
    Cell Death Dis; 2019 Nov; 10(11):865. PubMed ID: 31727879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The small molecule alpha-synuclein misfolding inhibitor, NPT200-11, produces multiple benefits in an animal model of Parkinson's disease.
    Price DL; Koike MA; Khan A; Wrasidlo W; Rockenstein E; Masliah E; Bonhaus D
    Sci Rep; 2018 Nov; 8(1):16165. PubMed ID: 30385782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.